Runze is a partner based in the Haiwen’s Shanghai office.

Runze joined Haiwen in 2015 and rejoined Haiwen in 2021.

Runze’s recent experiences including:

Hillhouse Capital in its acquisition of George Clinical, a leading, global clinical research organization;

Hillhouse Capital in its acquisition of Serta China and King Koil China;

Hillhouse Capital in its multiple domestic and cross-border investments;

PAG in its acquisition of Starx, a leading film theater chain in China;

Qingdao Guoxin (青岛国信) in its acquisition of CP Pharmaceutical Qingdao (正大制药青岛);

CITIC Capital in its sale of LifeStyles, one of world’s largest condom companies;

Demant A/S in its acquisition of Shengwang, a leading network of hearing aid clinics in China;

Bain Capital in its significant investment in EcoCeres, Inc., a subsidiary of The Hong Kong and China Gas Company Limited (Towngas) (HKSE: 0003);

Bain Capital in its acquisition of Evident Corporation from Olympus Corporation;

Bain Capital in its acquisition of VXI Global Solutions;

TruArc Partners in its acquisition of Molded Devices;

TruArc Partners in its acquisition of GlobalMed and Schauenburg-Truplast;

Cornell Capital in its acquisition of Advantek;

Alibaba in its joint venture with Unity Technologies and its multiple domestic or cross-border investments;

Ant Group in its multiple domestic or cross-border investments;

Baidu in its multiple domestic or cross-border investments;

Meituan in its multiple domestic or cross-border investments; and

CICC Capital in its multiple investments in China.

Runze received his LL.B. degree from Nanjing University and a Master of Arts degree from the Johns Hopkins University, SAIS, Nanjing Center and a LL.M degree from Harvard University. Runze is admitted to practice law in the PRC and passed the New York Bar Examination in 2019.

Runze’s native language is Mandarin, and he speaks English fluently.